Industry News
Pharmaceutical Industry News
Antibiotic Shortage Could Fuel Rise in Syphilis Rates
The primary drug used to treat the sexually transmitted infection could be scarce into next year, Pfizer warns.
What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA
Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.
FDA Makes Alzheimer’s Drug Leqembi Widely Accessible
The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.
Breakthroughs in Cancer Research and Treatment
Readers respond to Kate Pickert’s essay about the recent revolution in tackling cancer.
Retiree Medical Costs Expected to Stay Flat in 2023
An estimate puts the average cost over a 20-year retirement at about $157,000. That’s almost double the estimate in 2002.
How Vivek Ramaswamy Made the Fortune Fueling His Presidential Run
Mr. Ramaswamy calls himself a scientist from the biotech industry, but his vast fortune stems from two huge paydays that speak to hope and hype in the world of finance.
Ozempic en pastilla es una posibilidad
Una investigación publicada el domingo evalúa la efectividad del ingrediente activo en los medicamentos inyectables para la diabetes y la obesidad cuando se toman por vía oral.
How the Shortage of a $15 Cancer Drug Is Upending Treatment
Older generic chemotherapy drugs remain scarce, forcing doctors to put a priority on the patients who have the best chance of survival.
An Ozempic Pill Is On the Horizon: What to Know
Research published Sunday evaluates the effectiveness of the active ingredient in injectable diabetes and obesity drugs when taken orally.
La FDA aprueba Eroxon, un gel contra la disfunción eréctil
Según el fabricante de Eroxon, Futura Medical, el gel tópico “ayuda a los hombres a tener una erección en 10 minutos”.
Suddenly, It Looks Like We’re in a Golden Age for Medicine
We may be on the cusp of an era of astonishing innovation — the limits of which aren’t even clear yet.
Can Supplements Help You Focus?
Some manufacturers claim certain formulations can sharpen the mind, but experts say the evidence behind that idea is lacking.
Erectile Dysfunction Treatment: What to Know About Eroxon, a New Topical Gel
Eroxon, a topical gel, “helps men get an erection within 10 minutes,” according to Futura Medical, the manufacturer.
What Is ‘Food Noise’? How Ozempic Quiets Obsessive Thinking About Food
For some, it’s a startling side effect.
Approaches to Mental Illness
Readers respond to an Opinion guest essay by Daniel Bergner that questioned mandatory psychiatric treatment.
The Business of Being Chris Christie
Mr. Christie left the governor’s office in New Jersey and set out to, as he put it, “make money.” He successfully traded on his political profile — and on his ties to the man he
Cancer Drug Advancements Give New Hope to Metastatic Patients
New treatments are changing once deadly forms of the disease into manageable long-term illnesses. But not all patients are benefiting.
New Obesity Drugs Come With a Side Effect of Shaming
Wegovy and other drugs expose a social tension between a quest to medicate illness and a stigmatizing belief that obese people lack sufficient willpower to lose weight.
FDA Panel Recommends RSV Shot to Protect Infants
Advisers to the agency overwhelmingly agreed that a new treatment would help to prevent a potentially lethal respiratory illness in very young children.
When Politics Saves Lives: a Good-News Story
The decision to fund medications to treat H.I.V.-AIDS patients in sub-Saharan Africa and the Caribbean flew in the face of expert advice. But the U.S. did it anyway.